ImageneBio (IMA) Total Non-Current Liabilities (2023 - 2025)

ImageneBio has disclosed Total Non-Current Liabilities across 3 years of filings, most recently posting $19.0 million for Q4 2025.

• In Q4 2025, Total Non-Current Liabilities rose 8.71% year-over-year to $19.0 million; the TTM figure through Dec 2025 stood at $19.0 million (up 8.71% YoY), while the FY2025 annual figure was $19.0 million, up 8.71% from the prior year.
• Total Non-Current Liabilities came in at $19.0 million for Q4 2025 at ImageneBio, down from $19.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $21.4 million in Q4 2023 to a low of $9.2 million in Q2 2025.
• Average Total Non-Current Liabilities over 3 years is $15.8 million, with a median of $16.5 million recorded in 2024.
• The largest YoY upside for Total Non-Current Liabilities was 45.42% in 2025 against a maximum downside of 32.56% in 2025.
• Over 3 years, Total Non-Current Liabilities stood at $21.4 million in 2023, then decreased by 18.41% to $17.4 million in 2024, then gained by 8.71% to $19.0 million in 2025.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $19.0 million in Q4 2025, $19.9 million in Q3 2025, and $9.2 million in Q2 2025.